Diagnostic and prognostic utility of PD-1 in B cell lymphomas

Disease Markers

Volumn 29, Issue 1, 2010, Pages 47-53

  Muenst, S ^a   Hoeller, S ^a   Willi, N ^b   Dirnhofer, S ^a   Tzankov, A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Kantonsspital Liestal   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM;

EID: 77957245739     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0725     Document Type: Article

References (25)

1. A. Tzankov, C. Meier, P. Hirschmann, P. Went, S.A. Pileri and S. Dirnhofer, Correlation of high numbers of intratumoralFOXP3+ regulatory T cells with improved survival in germinal centerlike diffuse large Bcell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma, Haematologica 93 (2008), 193-200. (Pubitemid 351397707)
2. A. Tzankov, I. Zlobec, P. Went, H. Robl, S. Hoeller and S. Dirnhofer, Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cutoff scores, Leuk Lymphoma 51 (2010), 199-212.
3. A. Tzankov, P. Went, A. Zimpfer and S. Dirnhofer, Tissue microarray technology: principles, pitfalls and perspectives - lessons learned from hematological malignancies, Exp Gerontol 40 (2005), 737-744. (Pubitemid 41265824)
4. A.M. Glas, L. Knoops, L. Delahaye et al., Geneexpression and immunohistochemical study of specific Tcell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma, J Clin Oncol 25 (2007), 390-398. (Pubitemid 350002987)
5. B. Chetaille, F. Bertucci, P. Finetti et al., Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome, Blood 113 (2009), 2765-3775.
6. C.P. Hans, D.D. Weisenburger, T.C. Greiner et al., Confirmation of the molecular classification of diffuse large Bcell lymphoma by immunohistochemistry using a tissue microarray, Blood 103 (2004), 275-282.
7. D. Atkins, K. Reiffen, C.L. Tegtmeier, H.Winther, M.S. Bonato and S. Storkel, Immunohistochemical detection of EGFR in paraffinembedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections, J Histochem Cytochem 52 (2004), 893-901. (Pubitemid 38857154)
8. D. de Jong, Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors, J Clin Oncol 10 (2005), 6358-6663. (Pubitemid 46218847)
9. D. Schmitter,M.Koss, E.Niederer, R.A. Stahel andG. Pichert, Tcell derived cytokines costimulate proliferation of CD40activated germinal centre as well as follicular lymphoma cells, Hematol Oncol 15 (1997), 197-207. (Pubitemid 28374888)
10. D.M. Dorfman, J.A. Brown, A. Shahsafaei and G.J. Freeman, Programmed death1 (PD1) is a marker of germinal centerassociated T cells and angioimmunoblastic Tcell lymphoma, Am J Surg Pathol 30 (2006), 802-810. (Pubitemid 44264969)
11. D.T. Umetsu, L. Esserman, T.A. Donlon, R.H. DeKruyff and R. Levy, Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones, J Immunol 144 (1990), 2550-2557. (Pubitemid 20136656)
12. G. Roncador, J.F.Garcia VerdesMontenegro, S. Tedoldi et al., Expression of two markers of germinal center T cells (SAP and PD1) in angioimmunoblastic Tcell lymphoma, Haematologica 92 (2007), 1059-1066. (Pubitemid 350144212)
13. H. Adams, P. Liebisch, P. Schmid, S. Dirnhofer and A. Tzankov, Diagnostic utility of the Bcell lineage markers CD20, CD79a, PAX5, and CD19 in paraffinembedded tissues from lymphoid neoplasms, Appl Immunohistochem Mol Morphol 17 (2009), 96-101.
14. H. Husson, A.S. Freedman, A.A. Cardoso et al., CXCL13 (BCA1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells, Br J Haematol 119 (2002), 492-495. (Pubitemid 35365504)
15. H.C. Probst, K. McCoy, T. Okazaki, T. Honjo and M. van den Broek, Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD1 and CTLA1, Nat Immunol 6 (2005), 280-286. (Pubitemid 41724765)
16. I. Zlobec, L. Terracciano, J.R. Jass and A. Lugli, Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer, Virchows Arch 451 (2007), 763-769. (Pubitemid 47497938)
17. J. Carreras, A. LopezGuillermo, G. Roncador et al., High numbers of tumorinfiltrating programmed cell death 1positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma, J Clin Oncol 27 (2009), 1470-1476.
18. K.R. Calvo, B. Dabir, A. Kovach, C. Devor, R. Bandle, A. Bond, J.H. Shih and E.S. Jaffe, IL4 protein expression and basal activation of Erk in vivo in follicular lymphoma, Blood 112 (2008), 3818-3826.
19. L. Chen, Coinhibitory molecules of the B7CD28 family in the control of Tcell immunity, Nat Rev Immunol 4 (2004), 336-347. (Pubitemid 38649276)
20. L. Xerri, B. Chetaille, N. Seriari, C. Attias, Y. Guillaume, C. Arnoulet and D. Olive, Programmed death 1 is a marker of angioimmunoblastic Tcell lymphoma and Bcell small lymphocytic lymphoma/chronic lymphocytic leukemia, Hum Pathol 39 (2008), 1050-1058.
21. S. Inoges, A. LopezDiaz de Cerio, N. Zabalegui et al., Prolonged idiotypic vaccination against follicular lymphoma, Leuk Lymphoma 50 (2009), 47-53.
22. S. Muenst, S. Dirnhofer and A. Tzankov, Distribution of PD1+ lymphocytes in reactive lymphadenopathies, Pathobiology 77 (2010), 24-27.
23. S.Muenst, S. Hoeller, S. Dirnhofer and A. Tzankov, Increased programmed death1 tumorinfiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival, Hum Pathol 40 (2009), 1715-1722.
24. Y. Kitazawa, M. Fujino, Q. Wang, H. Kimura, M. Azuma, M. Kubo, R. Abe and X. Li, Involvement of the programmed death1/ programmed death1 ligand pathway in CD4+CD25+ regulatory Tcell activity to suppress alloimmune responses, Transplantation 83 (2007), 774-782. (Pubitemid 46569197)
25. Y. Lachmann, C.R. Wood, T. Chernova et al., PDL2 is a second ligand for PD1 and inhibits T cell activation, Nat Immunol 2 (2001), 261-268. (Pubitemid 33706004)